Of worms, mice and man: an overview of experimental and clinical helminth-based therapy for inflammatory bowel disease
- PMID: 24603369
- DOI: 10.1016/j.pharmthera.2014.02.011
Of worms, mice and man: an overview of experimental and clinical helminth-based therapy for inflammatory bowel disease
Abstract
The incidence of inflammatory and autoimmune disorders is highest in well-developed countries which is directly related to their higher hygienic standards: it is suggested that the lack of exposure to helminths contributes to the susceptibility for immune-related diseases. Epidemiological, experimental and clinical data support the idea that helminths provide protection against immune-mediated diseases such as inflammatory bowel disease (IBD). The most likely mechanism for the suppression of immune responses by helminths is the release of helminth-derived immunomodulatory molecules. This article reviews the experimental and clinical studies investigating the therapeutic potential of helminth-based therapy in IBD and also focuses on the current knowledge of its immunomodulatory mechanisms of action highlighting innate as well as adaptive immune mechanisms. Identifying the mechanisms by which these helminths and helminth-derived molecules modulate the immune system will help in creating novel drugs for the treatment of IBD and other disorders that result from an overactive immune response.
Keywords: Colitis; Helminth-derived molecules; Helminths; Inflammatory bowel disease; Innate and adaptive immunity; Therapy.
Copyright © 2014 Elsevier Inc. All rights reserved.
Similar articles
-
Worms and the treatment of inflammatory bowel disease: are molecules the answer?Clin Dev Immunol. 2008;2008:567314. doi: 10.1155/2008/567314. Clin Dev Immunol. 2008. PMID: 18509490 Free PMC article. Review.
-
Helminths as governors of immune-mediated inflammation.Int J Parasitol. 2007 Apr;37(5):457-64. doi: 10.1016/j.ijpara.2006.12.009. Epub 2006 Dec 28. Int J Parasitol. 2007. PMID: 17313951 Review.
-
Translatability of helminth therapy in inflammatory bowel diseases.Int J Parasitol. 2013 Mar;43(3-4):245-51. doi: 10.1016/j.ijpara.2012.10.016. Epub 2012 Nov 21. Int J Parasitol. 2013. PMID: 23178819 Free PMC article. Review.
-
Where are we on worms?Curr Opin Gastroenterol. 2012 Nov;28(6):551-6. doi: 10.1097/MOG.0b013e3283572f73. Curr Opin Gastroenterol. 2012. PMID: 23079675 Free PMC article. Review.
-
Do We Need Worms to Promote Immune Health?Clin Rev Allergy Immunol. 2015 Oct;49(2):227-31. doi: 10.1007/s12016-014-8458-3. Clin Rev Allergy Immunol. 2015. PMID: 25326880 Review.
Cited by
-
Novel antiinflammatory biologics shaped by parasite-host coevolution.Proc Natl Acad Sci U S A. 2022 Sep 6;119(36):e2202795119. doi: 10.1073/pnas.2202795119. Epub 2022 Aug 29. Proc Natl Acad Sci U S A. 2022. PMID: 36037362 Free PMC article.
-
Animal models of inflammatory bowel disease: category and evaluation indexes.Gastroenterol Rep (Oxf). 2024 Apr 16;12:goae021. doi: 10.1093/gastro/goae021. eCollection 2024. Gastroenterol Rep (Oxf). 2024. PMID: 38634007 Free PMC article. Review.
-
Larval Echinococcus multilocularis infection reduces dextran sulphate sodium-induced colitis in mice by attenuating T helper type 1/type 17-mediated immune reactions.Immunology. 2018 May;154(1):76-88. doi: 10.1111/imm.12860. Epub 2017 Dec 8. Immunology. 2018. PMID: 29121394 Free PMC article.
-
The intestinal milieu influences the immunoproteome of male and female Heligmosomoides polygyrus bakeri L4 stage.Parasitology. 2020 Nov;147(13):1480-1487. doi: 10.1017/S0031182020001201. Epub 2020 Jul 30. Parasitology. 2020. PMID: 32729450 Free PMC article.
-
The schistosome glutathione S-transferase P28GST, a unique helminth protein, prevents intestinal inflammation in experimental colitis through a Th2-type response with mucosal eosinophils.Mucosal Immunol. 2016 Mar;9(2):322-35. doi: 10.1038/mi.2015.62. Epub 2015 Jul 15. Mucosal Immunol. 2016. PMID: 26174763 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical